Sri Lanka approves Chinese Sinovac vaccine for emergency use

Sinovac CoronaVac has been developed by Sinovac/China National Pharmaceutical Group.
Sri Lanka has approved the emergency use of the Chinese Sinovac vaccine against COVID-19. It is the second Chinese COVID-19 vaccine approved by Sri Lanka's National Medicines Regulatory Authority (NMRA), News First reported. The country has already been administrating China's Sinopharm vaccine. China on Thursday announced that it will donate another 1.6 million doses of the Sinopharm COVID-19 vaccine to Sri Lanka.
Besides this, Covishield, Sputnik and Pfizer vaccines are also being administrated in the country. Sinovac CoronaVac has been developed by Sinovac/China National Pharmaceutical Group. In June, the WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of the inactivated COVID-19 vaccine.

Related Keywords

China , Sri Lanka , Chinese , Sri Lankan , Gotabaya Rajapaksa , Sinovac Coronavac , Sri Lanka National Medicines Regulatory Authority , China National Pharmaceutical Group , Epidemiology Unit Of The Ministry Health , Sinovac China National Pharmaceutical Group , Health Ministry , Pfizer , Xinhua , Strategic Advisory Group Of Experts , Image Source , China National Pharmaceutical , Chinese Sinovac , National Medicines Regulatory Authority , News First , Advisory Group , Epidemiology Unit , President Gotabaya Rajapaksa , சீனா , ஸ்ரீ லங்கா , சீன , ஸ்ரீ லங்கன் , ஸ்ரீ லங்கா தேசிய மருந்துகள் ஒழுங்குமுறை அதிகாரம் , சீனா தேசிய மருந்து குழு , தொற்றுநோய் அலகு ஆஃப் தி அமைச்சகம் ஆரோக்கியம் , ஆரோக்கியம் அமைச்சகம் , ஃபைசர் , படம் மூல , சீனா தேசிய மருந்து , தேசிய மருந்துகள் ஒழுங்குமுறை அதிகாரம் , செய்தி முதல் , தொற்றுநோய் அலகு ,